Understanding of Psychotic Disorders in Children With 22q11.2DS

Recruiting now · Not applicable

Conditions studied: 22q11.2 Deletion Syndrome

In brief

The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome

Key facts

Study ID

NCT04639388

Run by

Hôpital le Vinatier

People needed

80

Starts

2020-11-13

Expected to finish

2026-09-30

Last updated by the study team

2025-07-30

Who can join

Age: 4 and older, up to 13. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of 22q11.2 deletion syndrome or no developmental disease
• Aged from 4 to 13 years old
• French language

You may not qualify if…

• Diagnosis of intellectual deficiency according to DSM 5 criteria
• Drug prescribed for somatic condition that could influence cerebral functioning

Where it is running

• Hopital Vinatier — Lyon, Auvergne-Rhône-Alpes, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.